XENE · NASDAQ · Biotechnology

Xenon Pharmaceuticals (XENE)

Develops azetukalner and ion-channel medicines for epilepsy, depression, and pain.

$39.18
After hours+0.10 (+0.27%)
At close$39.08(+0.22%)